HOW EFFICIENT IS IMMUNOLOGICAL SURVEILLANCE AGAINST CANCER AND WHY DOES IT FAIL ?
- 1 June 1974
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 303 (7866), 1097-1100
- https://doi.org/10.1016/s0140-6736(74)90569-8
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- CANCER CAUSED BY AN INHERITED SELECTIVE DEFECT IN IMMUNOLOGICAL SURVEILLANCEThe Lancet, 1973
- Immunosuppression and NeoplasiaKlinische Wochenschrift, 1973
- MALIGNANT TUMORS ARISING DE NOVO IN IMMUNOSUPPRESSED ORGAN TRANSPLANT RECIPIENTSTransplantation, 1972
- The Immune Reaction as a Stimulator of Tumor GrowthScience, 1972
- The Regulatory Influence of Activated T Cells on B Cell Responses to AntigenAdvances in Immunology, 1972
- Serum factors in tumor‐free patients cancelling the blocking of cell‐mediated tumor immunityInternational Journal of Cancer, 1971
- Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody ComplexesProceedings of the National Academy of Sciences, 1971
- Demonstration of cell‐mediated immunity to human neoplasms of various histological typesInternational Journal of Cancer, 1971
- Genetic Control of Specific Immune ResponsesAdvances in Immunology, 1969
- GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKÆMOGENESISThe Lancet, 1964